Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising
autologous biological treatment modality for the use in aesthetic and regenerative medicine …

Stem cell treatment and platelet-rich plasma (PRP) therapy are two significant issues in
regenerative medicine. Stem cells such as bone marrow mesenchymal stem cells, adipose …

In the past 20 years, the platelet concentrates have evolved from first-generation products,
ie, platelet-rich plasma (PRP) and plasma rich in growth factors to the second-generation …

Developing scaffolds that can provide cells and biological cues simultaneously in the defect
site is of interest in tissue engineering field. In this study, platelet lysate (PL) as an …

The goal of regenerative medicine is to achieve tissue regeneration. In the past, commonly
used techniques included autologous or allogeneic transplantation and stem cell therapy …

Numerous studies have explored the suitability of biocompatible materials in regenerative
medicine. Platelet concentrates are derived from centrifuged blood and are named …

Background Platelet-rich plasma (PRP) improves the healing of refractory wounds, and its
application is receiving more attention in the field of wound repair. However, when a …

Concentrated Growth Factors (CGF) represent new autologous (blood-derived biomaterial),
attracting growing interest in the field of regenerative medicine. In this study, the chemical …

Abstract Leukocyte-and Platelet-Rich Fibrin (L-PRF) is an autologous platelet concentrate,
consisting of a fibrin matrix enriched with platelets, leukocytes and a plethora of cytokines …

Efficacy of mixture of injectable‐platelet‐rich fibrin and type‐1 collagen particles on the closure
of through‐and‐through periapical bone defects: A randomized controlled trial - M - 2023 …